Jinling Pharmaceutical Co Ltd (000919) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Jinling Pharmaceutical Co Ltd (000919) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.01 Million ≈ $10.83 Million USD) by net assets (CN¥4.85 Billion ≈ $709.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Jinling Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Jinling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Jinling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jinling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanghai Koal Software Co Ltd
SHG:603232
0.000x
Jiangsu Yueda Investment Co Ltd
SHG:600805
0.002x
AVIT Ltd
SHE:300264
-0.688x
Sebang Global Battery Co Ltd
KO:004490
0.042x
Selamat Sempurna Tbk
JK:SMSM
0.072x
Mystate Ltd
AU:MYS
0.140x
Mattr Corp
TO:MATR
0.106x
Jinhe Biotechnology Co Ltd
SHE:002688
0.088x

Annual Cash Flow Conversion Efficiency for Jinling Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Jinling Pharmaceutical Co Ltd from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see 000919 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.85 Billion
≈ $709.50 Million
CN¥154.19 Million
≈ $22.56 Million
0.032x -26.26%
2023-12-31 CN¥3.68 Billion
≈ $539.22 Million
CN¥158.92 Million
≈ $23.26 Million
0.043x -39.97%
2022-12-31 CN¥3.63 Billion
≈ $530.75 Million
CN¥260.59 Million
≈ $38.13 Million
0.072x -13.04%
2021-12-31 CN¥3.53 Billion
≈ $517.22 Million
CN¥292.03 Million
≈ $42.73 Million
0.083x -8.93%
2020-12-31 CN¥3.43 Billion
≈ $502.38 Million
CN¥311.46 Million
≈ $45.58 Million
0.091x -33.30%
2019-12-31 CN¥3.42 Billion
≈ $501.14 Million
CN¥465.85 Million
≈ $68.17 Million
0.136x +1.78%
2018-12-31 CN¥3.25 Billion
≈ $475.00 Million
CN¥433.83 Million
≈ $63.48 Million
0.134x -7.89%
2017-12-31 CN¥3.05 Billion
≈ $446.88 Million
CN¥443.11 Million
≈ $64.84 Million
0.145x +360.72%
2016-12-31 CN¥3.05 Billion
≈ $446.75 Million
CN¥96.15 Million
≈ $14.07 Million
0.031x -56.65%
2015-12-31 CN¥2.92 Billion
≈ $427.95 Million
CN¥212.45 Million
≈ $31.09 Million
0.073x -33.36%
2014-12-31 CN¥2.75 Billion
≈ $402.55 Million
CN¥299.89 Million
≈ $43.88 Million
0.109x +3.48%
2013-12-31 CN¥2.57 Billion
≈ $376.72 Million
CN¥271.21 Million
≈ $39.69 Million
0.105x +11.91%
2012-12-31 CN¥2.47 Billion
≈ $360.82 Million
CN¥232.12 Million
≈ $33.97 Million
0.094x +26.66%
2011-12-31 CN¥2.33 Billion
≈ $340.26 Million
CN¥172.82 Million
≈ $25.29 Million
0.074x -8.07%
2010-12-31 CN¥2.20 Billion
≈ $321.83 Million
CN¥177.81 Million
≈ $26.02 Million
0.081x -11.82%
2009-12-31 CN¥2.05 Billion
≈ $300.70 Million
CN¥188.41 Million
≈ $27.57 Million
0.092x -43.58%
2008-12-31 CN¥1.88 Billion
≈ $274.89 Million
CN¥305.26 Million
≈ $44.67 Million
0.162x +168.31%
2007-12-31 CN¥1.95 Billion
≈ $285.26 Million
CN¥118.06 Million
≈ $17.28 Million
0.061x -25.72%
2006-12-31 CN¥1.70 Billion
≈ $248.57 Million
CN¥138.50 Million
≈ $20.27 Million
0.082x +16.56%
2005-12-31 CN¥1.56 Billion
≈ $228.64 Million
CN¥109.29 Million
≈ $15.99 Million
0.070x -35.69%
2004-12-31 CN¥1.47 Billion
≈ $214.99 Million
CN¥159.81 Million
≈ $23.38 Million
0.109x -7.32%
2003-12-31 CN¥1.38 Billion
≈ $201.81 Million
CN¥161.86 Million
≈ $23.69 Million
0.117x +11.72%
2002-12-31 CN¥1.24 Billion
≈ $181.58 Million
CN¥130.36 Million
≈ $19.08 Million
0.105x +26.04%
2001-12-31 CN¥1.11 Billion
≈ $162.39 Million
CN¥92.49 Million
≈ $13.53 Million
0.083x -61.78%
2000-12-31 CN¥1.06 Billion
≈ $155.22 Million
CN¥231.31 Million
≈ $33.85 Million
0.218x +458.19%
1999-12-31 CN¥1.02 Billion
≈ $148.96 Million
CN¥39.77 Million
≈ $5.82 Million
0.039x --

About Jinling Pharmaceutical Co Ltd

SHE:000919 China Drug Manufacturers - Specialty & Generic
Market Cap
$555.14 Million
CN¥3.79 Billion CNY
Market Cap Rank
#11840 Global
#3425 in China
Share Price
CN¥6.10
Change (1 day)
+0.49%
52-Week Range
CN¥6.04 - CN¥8.91
All Time High
CN¥16.21
About

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China and internationally. The company offers Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, multiple arteriosclerosis, phlebitis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, an… Read more